Curetis and OpGen Close Business Combination

- Following approval of shareholders, companies sign German transfer agreement

- Curetis GmbH and its subsidiaries Curetis USA Inc. and Ares Genetics GmbH are now wholly owned by OpGen, Inc.

- OpGen consideration shares to be distributed to Curetis N.V. shareholders and Curetis N.V. to be dissolved and delisted from Euronext

- Three Curetis N.V. Supervisory Board members resign to join newly formed OpGen Inc. board of directors

Amsterdam, The Netherlands, and Holzgerlingen, Germany, April 01, 2020, 10:00 pm CET - Curetis N.V. (in liquidation) (the "Company") today announced that the business combination between the Company and OpGen Inc. (“OpGen”) has successfully been completed. The signing of the German transfer agreement implementing the transfer of 100% of the shares in Curetis GmbH to a wholly-owned subsidiary of OpGen, and the transfer to the Company of 2,028,208 new OpGen shares issued as consideration for such transfer (the “OpGen Shares") has occurred effective today.

The liquidators of the Company will resolve upon a liquidation distribution, to the extent possible in advance, of the OpGen Shares to the shareholders pro rata to each share held by them on the distribution record date. The distribution record date will be announced by way of a press release. The OpGen Shares that are not distributed to the shareholders by way of the liquidation distribution in advance will be reserved to be sold by the liquidators to fund continuous operations of the Company until its delisting from Euronext Amsterdam and Brussels and its liquidation. The sale of OpGen Shares by the Company’s liquidators shall not exceed an aggregate of 20% of the received OpGen Shares.

Today, the Company also announced the new governance structure of the Company following its dissolution and the newly formed OpGen group. Oliver Schacht, PhD, Johannes Bacher, and Dr. Achim Plum, formerly managing directors of the Company, will act as liquidators of the Company. William E. Rhodes III, Prabhavathi Fernandes and Mario Crovetto resigned from the Company’s supervisory board effective today to join the board of directors of OpGen Inc., as non-executive directors. The OpGen board will be chaired by William E. Rhodes III going forward.